Predictable factors for lymph node metastasis in early gastric cancer analysis of clinicopathologic factors and biological markers

Adult Aged, 80 and over Male Adenocarcinoma Middle Aged Prognosis 3. Good health Immunoenzyme Techniques 03 medical and health sciences 0302 clinical medicine Meta-Analysis as Topic Gastrectomy Stomach Neoplasms Lymphatic Metastasis Biomarkers, Tumor Humans Female Neoplasm Invasiveness Early Detection of Cancer Aged Follow-Up Studies Neoplasm Staging Retrospective Studies
DOI: 10.1007/s13277-015-4721-3 Publication Date: 2016-01-05T12:55:21Z
ABSTRACT
Predicting lymph node metastasis (LNM) accurately is very important to decide treatment strategies preoperatively. The aim of this study was explore risk factors that predict the presence LNM in early gastric cancer (EGC). A total 230 patients with EGC who underwent curative gastrectomy adenectomy at Xinhua Hospital from January 2006 July 2014 were retrospectively reviewed. We studied relationship between clinicopathological factors, biological markers (p53, ki67, nm23, vascular endothelial growth factor (VEGF), epidermal receptor (EGFR), E-cadherin (E-cad), beta-catenin (b-catenin), glutathione S-transferase (GST), and topoisomerase II (Topo II)), by chi-square test logistic regression analysis. Meta-analyses further conducted review effects proteins (P53, E-cad, b-catenin) on ECG patients. detected 42 (18.3 %) Incidences distinct different tumor size (p = 0.044), depth submucosal invasion < 0.0001), P53 overexpression 0.004). Multivariate analysis indentified large (≥20 mm, odds ratio (OR) 2.168, p 0.041), submucosa (OR 4.000, 0.0005), 3.010, 0.022) independent meta-analysis revealed a significantly statistical association P53, b-catenin an increased OR 1.81, 0.017; 2.53, 0.0003; b-catenin, 0.53, 0.01). Tumor mm), (submucosa), may be helpful predictors Furthermore, results ki67 overexpression, abnormal expression associated EGC. need validation single studies.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (59)
CITATIONS (19)